![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ADCY2 | Human | 17alpha-ethynylestradiol | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY2 mRNA | CTD | PMID:17942748 | ADCY2 | Human | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | ADCY2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY2 mRNA | CTD | PMID:17942748 | ADCY2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADCY2 mRNA | CTD | PMID:32109520 | ADCY2 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Adcy2 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of ADCY2 mRNA | CTD | PMID:18648102 | ADCY2 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | bisphenol S results in decreased expression of ADCY2 mRNA | CTD | PMID:26186136 | ADCY2 | Human | acrylamide | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of ADCY2 mRNA | CTD | PMID:28959563 | ADCY2 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ADCY2 mRNA | CTD | PMID:32763439 | ADCY2 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of ADCY2 intron | CTD | PMID:30157460 | ADCY2 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of ADCY2 intron | CTD | PMID:30157460 | ADCY2 | Human | allethrin | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein | CTD | PMID:34896426 | ADCY2 | Human | alpha-amanitin | affects expression | ISO | Adcy2 (Mus musculus) | 6480464 | Alpha-Amanitin affects the expression of ADCY2 mRNA | CTD | PMID:38531469 | ADCY2 | Human | alpha-Zearalanol | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADCY2 mRNA and [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADCY2 mRNA | CTD | PMID:35163327 | ADCY2 | Human | ammonium chloride | affects expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ADCY2 mRNA | CTD | PMID:16483693 | ADCY2 | Human | amphotericin B | increases expression | EXP | | 6480464 | Amphotericin B analog results in increased expression of ADCY2 mRNA | CTD | PMID:28534445 | ADCY2 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ADCY2 gene | CTD | PMID:25304211 | ADCY2 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ADCY2 gene | CTD | PMID:25304211 | ADCY2 | Human | arsenite(3-) | increases expression | ISO | Adcy2 (Mus musculus) | 6480464 | arsenite results in increased expression of ADCY2 mRNA | CTD | PMID:33053406 | ADCY2 | Human | atrazine | affects methylation | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of ADCY2 gene | CTD | PMID:35440735 | ADCY2 | Human | Azoxymethane | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY2 mRNA | CTD | PMID:29950665 | ADCY2 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ADCY2 3' UTR | CTD | PMID:27901495 | ADCY2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of ADCY2 promoter | CTD | PMID:27901495 | ADCY2 | Human | benzo[e]pyrene | affects methylation | EXP | | 6480464 | benzo(e)pyrene affects the methylation of ADCY2 intron | CTD | PMID:30157460 | ADCY2 | Human | bisphenol A | increases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ADCY2 mRNA | CTD | PMID:26141625 | ADCY2 | Human | bisphenol A | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of ADCY2 mRNA and [bisphenol A co-treated with tributyltin] results in increased expression of ADCY2 protein | CTD | PMID:31129395 | ADCY2 | Human | bisphenol A | increases methylation | ISO | Adcy2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of ADCY2 gene | CTD | PMID:28505145 | ADCY2 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ADCY2 mRNA | CTD | PMID:27685785 | ADCY2 | Human | bisphenol A | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ADCY2 mRNA | CTD | PMID:25181051 | ADCY2 | Human | bisphenol F | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | 4 and 4'-bisphenol F results in decreased expression of ADCY2 mRNA | CTD | PMID:26186136 | ADCY2 | Human | choline | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADCY2 mRNA | CTD | PMID:20938992 | ADCY2 | Human | clofibrate | decreases expression | ISO | Adcy2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of ADCY2 mRNA | CTD | PMID:17585979 | ADCY2 | Human | clothianidin | increases expression | EXP | | 6480464 | clothianidin results in increased expression of ADCY2 mRNA | CTD | PMID:31626844 | ADCY2 | Human | cocaine | affects expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Cocaine affects the expression of ADCY2 mRNA | CTD | PMID:20187946 | ADCY2 | Human | copper atom | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of ADCY2 mRNA | CTD | PMID:26033743 | ADCY2 | Human | copper atom | increases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of ADCY2 mRNA | CTD | PMID:26033743 | ADCY2 | Human | copper(0) | increases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of ADCY2 mRNA | CTD | PMID:26033743 | ADCY2 | Human | copper(0) | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of ADCY2 mRNA | CTD | PMID:26033743 | ADCY2 | Human | cyhalothrin | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein | CTD | PMID:34896426 | ADCY2 | Human | cypermethrin | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein | CTD | PMID:34896426 | ADCY2 | Human | dextran sulfate | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY2 mRNA | CTD | PMID:29950665 | ADCY2 | Human | diazinon | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Diazinon results in decreased expression of ADCY2 mRNA | CTD | PMID:17452286 | ADCY2 | Human | dichlorine | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of ADCY2 mRNA | CTD | PMID:18636392 | ADCY2 | Human | divanadium pentaoxide | affects expression | ISO | Adcy2 (Mus musculus) | 6480464 | vanadium pentoxide affects the expression of ADCY2 mRNA | CTD | PMID:26210822 | ADCY2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ADCY2 | Human | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA | CTD | PMID:19244175 | ADCY2 | Human | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of ADCY2 mRNA | CTD | PMID:19244175 | ADCY2 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of ADCY2 mRNA | CTD | PMID:26272509 | ADCY2 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA | CTD | PMID:27188386 | ADCY2 | Human | ethanol | increases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Ethanol results in increased expression of ADCY2 mRNA | CTD | PMID:20655511 | ADCY2 | Human | ethanol | increases expression | ISO | Adcy2 (Mus musculus) | 6480464 | Ethanol results in increased expression of ADCY2 mRNA | CTD | PMID:30319688 | ADCY2 | Human | ethanol | affects splicing | ISO | Adcy2 (Mus musculus) | 6480464 | Ethanol affects the splicing of ADCY2 mRNA | CTD | PMID:30319688 | ADCY2 | Human | fenvalerate | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein | CTD | PMID:34896426 | ADCY2 | Human | flavonoids | increases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of ADCY2 mRNA | CTD | PMID:18035473 | ADCY2 | Human | folic acid | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADCY2 mRNA | CTD | PMID:20938992 | ADCY2 | Human | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of ADCY2 promoter | CTD | PMID:22847954 | ADCY2 | Human | genistein | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Genistein co-treated with estradiol-17-benzoate co-treated with Progesterone] results in increased expression of ADCY2 protein and [Genistein co-treated with estradiol-17-benzoate] results in increased expression of ADCY2 protein | CTD | PMID:26529183 | ADCY2 | Human | genistein | affects expression | ISO | Adcy2 (Mus musculus) | 6480464 | Genistein affects the expression of ADCY2 mRNA | CTD | PMID:32186404 | ADCY2 | Human | L-methionine | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADCY2 mRNA | CTD | PMID:20938992 | ADCY2 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of ADCY2 mRNA | CTD | PMID:28903495 | ADCY2 | Human | maneb | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ADCY2 mRNA | CTD | PMID:36117858 | ADCY2 | Human | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of ADCY2 mRNA | CTD | PMID:26272509 | ADCY2 | Human | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA | CTD | PMID:27188386 | ADCY2 | Human | methapyrilene | affects methylation | EXP | | 6480464 | Methapyrilene affects the methylation of ADCY2 intron | CTD | PMID:30157460 | ADCY2 | Human | methoxychlor | affects methylation | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of ADCY2 gene | CTD | PMID:35440735 | ADCY2 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of ADCY2 mRNA | CTD | PMID:23649840 | ADCY2 | Human | miconazole | decreases activity | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Miconazole results in decreased activity of ADCY2 protein | CTD | PMID:30607468 | ADCY2 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ADCY2 mRNA | CTD | PMID:20360939 | ADCY2 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ADCY2 mRNA | CTD | PMID:24768652 and PMID:25583101 | ADCY2 | Human | oxaliplatin | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of ADCY2 mRNA | CTD | PMID:25729387 | ADCY2 | Human | ozone | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of ADCY2 mRNA | CTD | PMID:18636392 | ADCY2 | Human | ozone | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADCY2 mRNA | CTD | PMID:34911549 | ADCY2 | Human | paraquat | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ADCY2 mRNA | CTD | PMID:36117858 | ADCY2 | Human | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of ADCY2 promoter | CTD | PMID:22847954 | ADCY2 | Human | perfluorohexanesulfonic acid | increases expression | ISO | Adcy2 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of ADCY2 mRNA | CTD | PMID:37995155 | ADCY2 | Human | perfluorooctanoic acid | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADCY2 mRNA and [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADCY2 mRNA | CTD | PMID:35163327 | ADCY2 | Human | phenethyl caffeate | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ADCY2 mRNA | CTD | PMID:20360939 | ADCY2 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of ADCY2 mRNA | CTD | PMID:26272509 | ADCY2 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA | CTD | PMID:27188386 | ADCY2 | Human | pirinixic acid | increases expression | ISO | Adcy2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ADCY2 mRNA | CTD | PMID:20813756 | ADCY2 | Human | pirinixic acid | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ADCY2 mRNA | CTD | PMID:19710929 | ADCY2 | Human | progesterone | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [Genistein co-treated with estradiol-17-benzoate co-treated with Progesterone] results in increased expression of ADCY2 protein | CTD | PMID:26529183 | ADCY2 | Human | pyrethrins | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Pyrethrins results in decreased expression of ADCY2 protein | CTD | PMID:34896426 | ADCY2 | Human | raloxifene | affects expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Raloxifene Hydrochloride affects the expression of ADCY2 mRNA | CTD | PMID:16079270 | ADCY2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ADCY2 | Human | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA | CTD | PMID:19244175 | ADCY2 | Human | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of ADCY2 mRNA | CTD | PMID:19244175 | ADCY2 | Human | silicon dioxide | decreases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in decreased expression of ADCY2 mRNA | CTD | PMID:22431001 | ADCY2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ADCY2 protein | CTD | PMID:21925251 | ADCY2 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ADCY2 mRNA | CTD | PMID:31533062 | ADCY2 | Human | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of ADCY2 promoter | CTD | PMID:22847954 | ADCY2 | Human | titanium dioxide | multiple interactions | ISO | Adcy2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY2 mRNA | CTD | PMID:29950665 | ADCY2 | Human | titanium dioxide | increases methylation | ISO | Adcy2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of ADCY2 gene | CTD | PMID:35295148 | ADCY2 | Human | titanium dioxide | decreases methylation | ISO | Adcy2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ADCY2 gene | CTD | PMID:35295148 | ADCY2 | Human | topotecan | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of ADCY2 mRNA | CTD | PMID:25729387 | ADCY2 | Human | tributylstannane | multiple interactions | ISO | Adcy2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of ADCY2 mRNA and [bisphenol A co-treated with tributyltin] results in increased expression of ADCY2 protein | CTD | PMID:31129395 | ADCY2 | Human | trichloroethene | increases expression | ISO | Adcy2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of ADCY2 mRNA | CTD | PMID:33387578 | ADCY2 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of ADCY2 mRNA | CTD | PMID:30510588 | ADCY2 | Human | triptonide | increases expression | ISO | Adcy2 (Mus musculus) | 6480464 | triptonide results in increased expression of ADCY2 mRNA | CTD | PMID:33045310 | ADCY2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ADCY2 mRNA | CTD | PMID:25979313 | ADCY2 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ADCY2 mRNA | CTD | PMID:23179753 more ... | ADCY2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA | CTD | PMID:27188386 | ADCY2 | Human | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA | CTD | PMID:19244175 | ADCY2 | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of ADCY2 mRNA | CTD | PMID:27188386 | |